Company
About the company
Orphalan develops and commercialises medicines for rare diseases. Its teams work with clinicians, healthcare systems and patient communities to provide treatments in specialist therapeutic areas. The UK operation forms part of a European pharmaceutical business and relies on third-party suppliers for many operational activities.
Company statement
Carbon claim
Orphalan UK commits to achieving net-zero emissions by 2045.
A short summary of publicly available information. We have not verified the carbon claim.
Read the public source